Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP508920.RA3rUSQr7pOjZ6qjQ095SJWl9HHonAtFKDbxuKyDhgXOw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP508920.RA3rUSQr7pOjZ6qjQ095SJWl9HHonAtFKDbxuKyDhgXOw130_assertion type Assertion NP508920.RA3rUSQr7pOjZ6qjQ095SJWl9HHonAtFKDbxuKyDhgXOw130_head.
- NP508920.RA3rUSQr7pOjZ6qjQ095SJWl9HHonAtFKDbxuKyDhgXOw130_assertion description "[Subsequent progression of oligodendroglial tumors appears to be triggered by additional molecular features underlying the transition to anaplastic oligodendroglioma and glioblastoma multiforme (GBM) such as deletions of 9p and 10q, and alterations of CDKN2A (p16), which is located at 9p21.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP508920.RA3rUSQr7pOjZ6qjQ095SJWl9HHonAtFKDbxuKyDhgXOw130_provenance.
- NP508920.RA3rUSQr7pOjZ6qjQ095SJWl9HHonAtFKDbxuKyDhgXOw130_assertion evidence source_evidence_literature NP508920.RA3rUSQr7pOjZ6qjQ095SJWl9HHonAtFKDbxuKyDhgXOw130_provenance.
- NP508920.RA3rUSQr7pOjZ6qjQ095SJWl9HHonAtFKDbxuKyDhgXOw130_assertion SIO_000772 16102584 NP508920.RA3rUSQr7pOjZ6qjQ095SJWl9HHonAtFKDbxuKyDhgXOw130_provenance.
- NP508920.RA3rUSQr7pOjZ6qjQ095SJWl9HHonAtFKDbxuKyDhgXOw130_assertion wasDerivedFrom befree-2016 NP508920.RA3rUSQr7pOjZ6qjQ095SJWl9HHonAtFKDbxuKyDhgXOw130_provenance.
- NP508920.RA3rUSQr7pOjZ6qjQ095SJWl9HHonAtFKDbxuKyDhgXOw130_assertion wasGeneratedBy ECO_0000203 NP508920.RA3rUSQr7pOjZ6qjQ095SJWl9HHonAtFKDbxuKyDhgXOw130_provenance.